PMHS — Polomar Health Services, Inc.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1265521 ·
Last close
$0.17
Market Cap
$4.82M
52W High
$0.80
52W Low
$0.06
ADV30
7,824
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 1,528,705 | 935,916 | 218,377 | 200,358 | 814,726 | 178,872 | 1,871,123 |
| Mar 2026 | 1,005,519 | 550,489 | -6,902 | -25,377 | 516,600 | 87,818 | 1,762,118 |
| Dec 2025 | 632,057 | 448,763 | -8,942,714 | -8,988,912 | 390,043 | 132,150 | 1,612,372 |
| Sep 2025 | 6,163 | 4,323 | -628,808 | -649,775 | 9,269,726 | 38,854 | 1,503,130 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-316,042
Investing CF
$0
Financing CF
$274,529
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.06
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-13,637,645
Inventory
$208,981
Receivables
$170,851
ST Investments
—
EBIT TTM
$-10,141,757
Pretax Income TTM
$-10,269,627
Interest Exp TTM
$127,870
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,172,444
EBITDA
$-85,973
Free Cash Flow
$3,569,896
Enterprise Value
$6,292,088
Total Cash
$178,872
Total Debt
$794,787
Shares Out
28,380,868
Trailing EPS
$-0.35
Book Value
$-0.04
ROE
-257.9%
ROA
-114.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 648,231 | -10,550,264 | -10,701,105 | 390,043 | 1,612,372 | -1,222,329 | -395,995 |
| Dec 2024 | 58,824 | -1,299,496 | -1,341,333 | 9,951,773 | 1,352,642 | 8,599,131 | -1,019,787 |
| Dec 2023 | 41,844 | -440,832 | -587,997 | 107,099 | 151,635 | -44,536 | -534,307 |
| Dec 2022 | 34,526 | -181,453 | -181,124 | 261,484 | 74,715 | 186,769 | -40,934 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| EMMA | Emmaus Life Sciences, Inc. | $4.76M | $0.07 | — |
| ADTX | Aditxt, Inc. | $4.99M | $0.00 | — |
| CANF | Can-Fite BioPharma Ltd. | $4.63M | $2.16 | — |
| ADXN | Addex Therapeutics Ltd. | $4.62M | $3.65 | — |
| PCSA | Processa Pharmaceuticals, Inc. | $5.14M | $1.84 | — |
News headlines (Yahoo Finance, 1h cache)
Polomar Health Services Reports Second-Quarter Revenue of $1.53 Million and Positive Net Income
2026-08-18 12:30 · Yahoo
Polomar Health Services Strengthens Board Leadership to Support Standalone Growth Strategy
2026-07-08 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.